NanJing Pharmaceutical Company Limited (600713.SS)
CNY 5.2
(-0.38%)
CNY 5.2
(-0.38%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 5.79 Billion CNY | 0.18% |
| 2022 | 5.78 Billion CNY | 28.1% |
| 2021 | 4.51 Billion CNY | 11.12% |
| 2020 | 4.06 Billion CNY | 9.36% |
| 2019 | 3.71 Billion CNY | 26.37% |
| 2018 | 2.94 Billion CNY | 11.6% |
| 2017 | 2.63 Billion CNY | 2.52% |
| 2016 | 2.57 Billion CNY | 23.33% |
| 2015 | 2.08 Billion CNY | 21.35% |
| 2014 | 1.71 Billion CNY | 13.82% |
| 2013 | 1.5 Billion CNY | 16.15% |
| 2012 | 1.29 Billion CNY | -9.14% |
| 2011 | 1.43 Billion CNY | 11.91% |
| 2010 | 1.27 Billion CNY | 10.38% |
| 2009 | 1.15 Billion CNY | 35.79% |
| 2008 | 852.66 Million CNY | -7.99% |
| 2007 | 926.7 Million CNY | 33.04% |
| 2006 | 696.57 Million CNY | 4.68% |
| 2005 | 665.44 Million CNY | 10.94% |
| 2004 | 599.83 Million CNY | 9.77% |
| 2003 | 546.42 Million CNY | 11.99% |
| 2002 | 487.94 Million CNY | 121.55% |
| 2001 | 220.24 Million CNY | 15.1% |
| 2000 | 191.34 Million CNY | 20.75% |
| 1999 | 158.46 Million CNY | 53.65% |
| 1998 | 103.13 Million CNY | 40.96% |
| 1997 | 73.16 Million CNY | -16.33% |
| 1996 | 87.45 Million CNY | 21.59% |
| 1995 | 71.92 Million CNY | -5.58% |
| 1994 | 76.16 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 5.87 Billion CNY | 1.28% |
| 2024 Q2 | 5.91 Billion CNY | 0.7% |
| 2024 Q3 | 6.02 Billion CNY | 1.95% |
| 2023 Q1 | 6.18 Billion CNY | 6.91% |
| 2023 Q4 | 5.79 Billion CNY | 1.78% |
| 2023 Q3 | 5.69 Billion CNY | -4.82% |
| 2023 Q2 | 5.98 Billion CNY | -3.26% |
| 2023 FY | 5.79 Billion CNY | 0.18% |
| 2022 Q3 | 5.14 Billion CNY | 4.64% |
| 2022 Q1 | 5.29 Billion CNY | 17.17% |
| 2022 FY | 5.78 Billion CNY | 28.1% |
| 2022 Q4 | 5.78 Billion CNY | 12.48% |
| 2022 Q2 | 4.91 Billion CNY | -7.12% |
| 2021 Q2 | 4.65 Billion CNY | 0.11% |
| 2021 Q1 | 4.65 Billion CNY | 14.41% |
| 2021 FY | 4.51 Billion CNY | 11.12% |
| 2021 Q4 | 4.51 Billion CNY | 0.2% |
| 2021 Q3 | 4.5 Billion CNY | -3.17% |
| 2020 FY | 4.06 Billion CNY | 9.36% |
| 2020 Q1 | 4.36 Billion CNY | 17.54% |
| 2020 Q2 | 3.85 Billion CNY | -11.87% |
| 2020 Q3 | 4.05 Billion CNY | 5.4% |
| 2020 Q4 | 4.06 Billion CNY | 0.15% |
| 2019 Q2 | 3.44 Billion CNY | 0.16% |
| 2019 Q4 | 3.71 Billion CNY | -4.67% |
| 2019 Q3 | 3.89 Billion CNY | 13.17% |
| 2019 Q1 | 3.44 Billion CNY | 16.94% |
| 2019 FY | 3.71 Billion CNY | 26.37% |
| 2018 Q3 | 3.19 Billion CNY | 13.78% |
| 2018 FY | 2.94 Billion CNY | 11.6% |
| 2018 Q4 | 2.94 Billion CNY | -7.93% |
| 2018 Q2 | 2.8 Billion CNY | -4.87% |
| 2018 Q1 | 2.95 Billion CNY | 11.99% |
| 2017 Q4 | 2.63 Billion CNY | 0.68% |
| 2017 FY | 2.63 Billion CNY | 2.52% |
| 2017 Q3 | 2.61 Billion CNY | 9.43% |
| 2017 Q2 | 2.39 Billion CNY | -11.0% |
| 2017 Q1 | 2.68 Billion CNY | 4.55% |
| 2016 Q1 | 2.24 Billion CNY | 7.79% |
| 2016 Q3 | 2.54 Billion CNY | 21.85% |
| 2016 FY | 2.57 Billion CNY | 23.33% |
| 2016 Q2 | 2.09 Billion CNY | -7.0% |
| 2016 Q4 | 2.57 Billion CNY | 0.96% |
| 2015 Q2 | 1.82 Billion CNY | -3.04% |
| 2015 Q1 | 1.88 Billion CNY | 9.69% |
| 2015 Q3 | 2.08 Billion CNY | 14.08% |
| 2015 Q4 | 2.08 Billion CNY | 0.03% |
| 2015 FY | 2.08 Billion CNY | 21.35% |
| 2014 FY | 1.71 Billion CNY | 13.82% |
| 2014 Q1 | 1.43 Billion CNY | -4.68% |
| 2014 Q2 | 1.35 Billion CNY | -5.58% |
| 2014 Q3 | 1.67 Billion CNY | 23.04% |
| 2014 Q4 | 1.71 Billion CNY | 2.79% |
| 2013 Q1 | 1.16 Billion CNY | -10.57% |
| 2013 Q2 | 1.17 Billion CNY | 1.09% |
| 2013 Q3 | 1.36 Billion CNY | 16.25% |
| 2013 Q4 | 1.5 Billion CNY | 10.53% |
| 2013 FY | 1.5 Billion CNY | 16.15% |
| 2012 Q2 | 1.27 Billion CNY | -9.08% |
| 2012 Q3 | 1.33 Billion CNY | 4.39% |
| 2012 Q4 | 1.29 Billion CNY | -2.6% |
| 2012 FY | 1.29 Billion CNY | -9.14% |
| 2012 Q1 | 1.4 Billion CNY | -1.71% |
| 2011 Q2 | 1.2 Billion CNY | -10.01% |
| 2011 Q4 | 1.43 Billion CNY | 7.26% |
| 2011 Q3 | 1.33 Billion CNY | 10.83% |
| 2011 Q1 | 1.33 Billion CNY | 4.61% |
| 2011 FY | 1.43 Billion CNY | 11.91% |
| 2010 FY | 1.27 Billion CNY | 10.38% |
| 2010 Q4 | 1.27 Billion CNY | 13.54% |
| 2010 Q1 | 1.13 Billion CNY | -1.78% |
| 2010 Q3 | 1.12 Billion CNY | -1.05% |
| 2010 Q2 | 1.13 Billion CNY | 0.03% |
| 2009 Q2 | 939.78 Million CNY | 10.66% |
| 2009 FY | 1.15 Billion CNY | 35.79% |
| 2009 Q4 | 1.15 Billion CNY | 10.97% |
| 2009 Q1 | 849.27 Million CNY | -0.4% |
| 2009 Q3 | 1.04 Billion CNY | 11.02% |
| 2008 Q1 | 953.09 Million CNY | 2.85% |
| 2008 Q2 | 951.44 Million CNY | -0.17% |
| 2008 FY | 852.66 Million CNY | -7.99% |
| 2008 Q3 | 993.84 Million CNY | 4.46% |
| 2008 Q4 | 852.66 Million CNY | -14.21% |
| 2007 Q4 | 926.7 Million CNY | 1.97% |
| 2007 Q3 | 908.82 Million CNY | 3.97% |
| 2007 Q2 | 874.12 Million CNY | 22.83% |
| 2007 Q1 | 711.63 Million CNY | 2.16% |
| 2007 FY | 926.7 Million CNY | 33.04% |
| 2006 FY | 696.57 Million CNY | 4.68% |
| 2006 Q1 | 702.75 Million CNY | 5.61% |
| 2006 Q2 | 659.34 Million CNY | -6.18% |
| 2006 Q3 | 652.46 Million CNY | -1.04% |
| 2006 Q4 | 696.57 Million CNY | 6.76% |
| 2005 FY | 665.44 Million CNY | 10.94% |
| 2005 Q4 | 665.44 Million CNY | -1.33% |
| 2005 Q3 | 674.43 Million CNY | 4.36% |
| 2005 Q2 | 646.25 Million CNY | 7.39% |
| 2005 Q1 | 601.8 Million CNY | 0.33% |
| 2004 Q1 | 504.68 Million CNY | -7.64% |
| 2004 Q2 | 521.87 Million CNY | 3.41% |
| 2004 Q3 | 579.02 Million CNY | 10.95% |
| 2004 FY | 599.83 Million CNY | 9.77% |
| 2004 Q4 | 599.83 Million CNY | 3.59% |
| 2003 Q2 | 574.98 Million CNY | 35.03% |
| 2003 FY | 546.42 Million CNY | 11.99% |
| 2003 Q4 | 546.42 Million CNY | 0.38% |
| 2003 Q3 | 544.33 Million CNY | -5.33% |
| 2003 Q1 | 425.83 Million CNY | -12.73% |
| 2002 FY | 487.94 Million CNY | 121.55% |
| 2002 Q1 | 269.76 Million CNY | 22.49% |
| 2002 Q2 | 283.86 Million CNY | 5.23% |
| 2002 Q3 | 282.3 Million CNY | -0.55% |
| 2002 Q4 | 487.94 Million CNY | 72.84% |
| 2001 Q4 | 220.24 Million CNY | 0.0% |
| 2001 Q2 | 188.39 Million CNY | 0.0% |
| 2001 FY | 220.24 Million CNY | 15.1% |
| 2000 Q4 | 191.34 Million CNY | 0.0% |
| 2000 FY | 191.34 Million CNY | 20.75% |
| 2000 Q2 | 185.55 Million CNY | 0.0% |
| 1999 Q2 | 115.56 Million CNY | 0.0% |
| 1999 Q4 | 158.46 Million CNY | 0.0% |
| 1999 FY | 158.46 Million CNY | 53.65% |
| 1998 Q2 | 75.19 Million CNY | 0.0% |
| 1998 FY | 103.13 Million CNY | 40.96% |
| 1998 Q4 | 103.13 Million CNY | 0.0% |
| 1997 FY | 73.16 Million CNY | -16.33% |
| 1997 Q4 | 73.16 Million CNY | 0.0% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 Q2 | - CNY | 0.0% |
| 1996 Q4 | 87.45 Million CNY | 0.0% |
| 1996 FY | 87.45 Million CNY | 21.59% |
| 1995 Q4 | 71.92 Million CNY | 0.0% |
| 1995 FY | 71.92 Million CNY | -5.58% |
| 1994 FY | 76.16 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 2.31 Billion CNY | -150.559% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.37 Billion CNY | -71.607% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.33 Billion CNY | -334.969% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 242.85 Million CNY | -2287.392% |
| Aurora Optoelectronics Co.,Ltd. | 70.61 Million CNY | -8110.218% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 42.94 Million CNY | -13400.566% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 569.53 Million CNY | -918.033% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 705.34 Million CNY | -722.009% |